What is the Impact Factor of Experimental Oncology?

The journal Experimental Oncology is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Experimental Oncology indexed in Web of Science or Scopus?

Yes, Experimental Oncology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.261 (Q4) and an H-index of 52.

Who publishes Experimental Oncology and what is the Article Processing Charge (APC)?

Experimental Oncology is published by Morion LLC. The estimated Article Processing Charge (APC) is approximately $2,587 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q4SCImago #18,744Subscription

Experimental Oncology

Identifier (ISSN):1812-9269(Print)

•

Publisher:Morion LLC

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Experimental Oncology

WoS Q1

Annual Impact Factor Metric

Current (2023):0

Scopus SJR & RankScopus Q4

0.261

#18,744

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

52 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

35articles/year

0% Gold OA•0% Original Research

Aims & Scope

The Experimental Oncology is an English-language journal that publishes review articles, original contributions, short communications, case reports and technical advances presenting new data in the field of experimental and fundamental oncology. Manuscripts should be written in English, contain original work, which has not been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to “Experimental Oncology”. No part of journal publications may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior permission of the publisher.

Topics Covered (Recognized by AI)

Biology93.3%Medicine92.1%Genetics90.4%Internal medicine85.7%Chemistry74.1%Biochemistry70.4%Cancer57%Pathology48.9%Immunology45.4%Cancer research43.5%Gene38.8%Surgery30.8%Physics27.4%Endocrinology26.1%Organic chemistry24.9%Oncology23.6%Cell biology22.5%Molecular biology22.1%In vitro21.2%

Primary Research Areas

Medicine Oncology

NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF—

Articles / Year35

Total Citations3

2025

IF—

Articles / Year69

Total Citations43

2024

IF—

Articles / Year54

Total Citations135

2023

IF0

Articles / Year105

Total Citations316

2022

IF—

Articles / Year16

Total Citations73

Year	Impact Factor	Articles / Year	Total Citations
2026	—	35	3
2025	—	69	43
2024	—	54	135
2023	0	105	316
2022	—	16	73
2021	—	69	252
2020	—	60	409
2019	—	63	574
2018	—	59	514
2017	—	54	478
2016	—	56	460
2015	—	57	612

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,744Scopus Q4SCImago Profile

Scopus Coverage:1984-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q4

0.261

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

1.00

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,587 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations157

3-Year Documents172

Citable Documents167

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ4

OncologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Experimental Oncology (ISSN: 1812-9269) is a peer-reviewed international scholarly journal in the field of Medicine, published by Morion LLC in Ukraine. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.261 (Q4), an H-index of 52.

The journal enforces rigorous peer evaluation with an annual output of approximately 35 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,587 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.